Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Kemin capsule for post-infectious cough
ChiCTR1900026505Phase 2Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of clemastine in postinfectious cough (3 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Cough disappearance time and Incidence of clinical adverse events/reactions. Started Oct 2019; status: recruiting.
02
Drugs
clemastine
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on ChiCTR1900026505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026505.